Albert Schweitzer Ziekenhuis, Netherlands: Clinical Trials

3 trials sponsored by Albert Schweitzer Ziekenhuis, Netherlands, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. .

Follow Albert Schweitzer Ziekenhuis, Netherlands: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure
Percutaneous coronary intervention with protocolized implantation of a second generation thin-strut bioresorbable scaffold guided by intracoronary imaging - Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)
RecruitingAlbert Schweitzer Ziekenhuis, Netherlands1172025-11-042026-05-18
Bascom Cleft Lift for Primary Wound Healing in Complex and Recurrent Sacrococcygeal Pilonidal Sinus Disease
Pilonidal Sinus
RecruitingAlbert Schweitzer Ziekenhuis, Netherlands582025-02-202025-09-30
An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)
no intervention - Breast Fibrosis, Breast Cancer
CompletedErasmus Medical Center7752022-04-112026-04-13

Conditions studied

Breast Carcinoma In Situ (1)  ·  Breast Neoplasms (1)  ·  Fibrosis (1)  ·  Pilonidal Sinus (1)

Interventions

Percutaneous Coronary Intervention (1)

Countries

Netherlands (3)

Top investigators

Boudewijn Toorenvliet, MD, PhD (1)  ·  R.A. Nout, Professor (1)  ·  Robert Smeenk, MD, PhD (1)

Results publications

PMID 40774221